Related references
Note: Only part of the references are listed.Moxifloxacin-Containing Triple Therapy versus Bismuth-Containing Quadruple Therapy for Second-Line Treatment of Helicobacter pylori Infection: A Meta-Analysis
Cheng Wu et al.
HELICOBACTER (2011)
Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial
Josip Bago et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2010)
Prevalence of Primary Fluoroquinolone Resistance Among Clinical Isolates of Helicobacter pylori at a University Hospital in Southern Taiwan
Kuei-Hsiang Hung et al.
HELICOBACTER (2009)
Moxifloxacin-Based Triple Therapy Versus Clarithromycin-Based Triple Therapy for First-Line Treatment of Helicobacter pylori Infection: A Meta-Analysis of Randomized Controlled Trials
Yuan Wenzhen et al.
INTERNAL MEDICINE (2009)
Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan
Wei-Lun Chang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Frequency and molecular characteristics of ciprofloxacin- and rifampicin-resistant Helicobacter pylori from gastric infections in the UK
Stephanie A. Chisholm et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2009)
Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial
Josip Bago et al.
WIENER KLINISCHE WOCHENSCHRIFT (2009)
S3-Guideline Helicobacter pylori and gastroduodenal ulcer disease of the German Society for Digestive and Metabolic Diseases (DGVS) in cooperation with the German Society for Hygiene and Microbiology, Society for Pediatric Gastroenterology and Nutrition e.V., German Society for Rheumatology, AWMF-Registration-no. 021/001
W. Fischbach et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2009)
Moxifloxacine Plus Amoxicillin and Ranitidine Bismuth Citrate or Esomeprazole Triple Therapies for Helicobacter pylori Infection
Zeki Mesut Yalm Kilic et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates
M. Romano et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
Second-line treatment for Helicobacter pylori infection:: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy
Jung Mook Kang et al.
HELICOBACTER (2007)
First-line triple therapy with levofloxacin for Helicobacter pylori eradication
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
American college of gastroenterology guideline on the management of Helicobacter pylori infection
William D. Chey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy
A. Zullo et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Current concepts in the management of Helicobacter pylori infection:: the maastricht III consensus report
P. Malfertheiner et al.
GUT (2007)
Hohe eradikationsrate von H-Pylori mit moxifloxacin-basierter therapie:: Eine randomisierte kontrollierte studie
Petra Bago et al.
WIENER KLINISCHE WOCHENSCHRIFT (2007)
Quinolone resistance in Helicobacter pylori isolates in Germany
Erik Glocker et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan
Hideyuki Miyachi et al.
HELICOBACTER (2006)
Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole
Leonardo Marzio et al.
HELICOBACTER (2006)
Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection
JH Cheon et al.
HELICOBACTER (2006)
Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection
EC Nista et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
H pylori antibiotic resistance:: prevalence, importance, and advances in testing
F Mégraud
GUT (2004)
Moxifloxacin - A review of its use in the management of bacterial infections
GM Keating et al.
DRUGS (2004)
Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori
J Tankovic et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Treatment of Helicobacter pylori infection
F Perri et al.
HELICOBACTER (2003)
Helicobacter pylori 'rescue' regimen when proton pump inhibitor-based triple therapies fail
JP Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection
M Hojo et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2001)
Randomised study of the efficacy of Omeprazole and Clarithromycin with either Amoxycillin or Metronidazole in the eradication of Helicobacter pylori in screened primary care patients
PM Neville et al.
DIGESTIVE AND LIVER DISEASE (2001)
Rabeprazole, amoxycillin and low- or high-dose clarithromycin for cure of Helicobacter pylori infection
K Kihira et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2000)
Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy
M Heep et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2000)
Share Paper
